Altogether, genomic analyses of key steroidogenic factors, within the context of TCGA breast cancer datasets, indicated that aberrant amplification/ expression of the StAR gene is involved, at least in part, in poor survival of ER+/PR+ breast cancer patients. This evidence concerns the gene ESR1 and breast cancer.